related documents
- 4D Reconstruction of dynamic studies performed using Discovery NM 530c Conferences
- A novel gallium-68 labelled pteroate for visualization of folate receptor positive tumors Conferences
- An Approach to New Oncologic PET Agent Development Conferences
- Calibration Procedures for Multi-Center Dosimetry Studies with 177Lu Radiopharmaceuticals: Experience from the Canadian Cancer Trial Group PR.21 Trial (NCT 04663997) Conferences
- Development of a North American supply of holmium-166 microspheres for Selective Internal Radiation Therapy (SIRT) of liver malignancies Conferences
- Diagnostic accuracy of SPECT for mild traumatic brain injury: a systematic review and meta-analysis Conferences
- Evaluation of refractory epilepsy in children using 3D-SSP (NEUROSTAT) and FDG-PET Conferences
- F-18-DCFPyL PET/CT in Castration-Resistant Prostate Cancer (CRPC): Imaging results prior to and following abiraterone or enzalutemide therapy Conferences
- First outcomes from OZM-067-a multicenter single arm study of 177Lu-DOTATATE therapy for primary site agnostic 68Ga-DOTATATE PET positive progressive metastatic neuroendocrine tumors Conferences
- Individualized dosimetry for Lu177 DOTATATE therapy - What difference does it make? Conferences
- PET and MRI associations across a spectrum of pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC) Conferences
- PSMA imaging with F-18-DCFPyL: evaluation of different normalization methods for uptake measurement Conferences
- Prognostic value of baseline evaluation of FDG and NaF PET/CT in castrate-resistant prostate cancer (CRPC): Early results from a prospective phase 1 trial Conferences
- Radiosynthesis and Development of Peptide Decorated Dendrimers as a Drug Delivery Platform for Oncological Application Conferences
- The contribution of multiparametric pelvic and whole body MR to the interpretation of F-18-fluoromethylcholine(FCH) or Ga-68-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy. Conferences